Eight in Ten AI Health Users Still Check Elsewhere

A patient asking an AI tool to explain a test result is not necessarily choosing that tool over a clinician, hospital website or recognised health-information service. More often, they are starting a chain of enquiry.

That distinction matters. New research from Luth Research, based on passive digital tracking of 1,538 consumers and a survey of 537 people who had used AI for health information, found that roughly four in five AI users also consulted other sources. Health-information sites were the leading companion source. AI supplied speed and simpler language; established sources played a larger part when people prepared for appointments or weighed treatment decisions.

This is an early US study, rather than a measure of UK patient behaviour, and it should not be overextended. Yet its central finding is commercially useful across health systems: AI appears to add a verification stage to the patient journey. It does not simply remove the need for authoritative patient information.

For healthcare providers, charities, life-sciences firms and digital-health businesses, the implication is more demanding than a conventional content-marketing brief. The task is not merely to be discoverable in an AI-shaped information environment. It is to make the next step credible, comprehensible and useful enough for someone who has arrived with a provisional answer already in mind.

AI is becoming the explainer, not the final authority

The roles patients assign to different channels are becoming clearer. Luth found that people use AI to explore a clinician’s explanation in greater depth and because it can feel easier than asking a doctor another question. That is a service-design signal as much as a communications one. Patients are often trying to close gaps in time, confidence, language or recall.

The Consumer Technology Association reported a similar pattern this month: 41% of US consumers now incorporate AI and/or social media into non-emergency healthcare journeys, while 85% say they verify information from those channels. Taken together, the studies point to a layered behaviour rather than a wholesale transfer of trust.

AI is especially well suited to the first, private questions: *What does this term mean? Is this symptom worth raising? What should I ask at my appointment?* It reduces the effort required to formulate a question, and it can translate clinical language into a more usable starting point.

But a diagnosis, a treatment trade-off and a decision about where to seek care carry different stakes. At that point, patients look for provenance, specificity and a route into action. They want information that applies to the service, pathway, medicine or condition in front of them — and they need to know what to do next.

That is why an organisation should resist treating AI referrals as just another acquisition channel. The more useful lens is decision support across a fragmented journey.

The weak point is often the hand-off

A patient may arrive at a provider’s site informed, anxious and holding an AI-generated summary. Too many health websites make the next move harder: generic condition pages, unexplained eligibility rules, outdated clinic details, PDFs that do not work well on a phone, or a contact route that forces the visitor to start again.

The resulting frustration is easily misread. A team may conclude that AI information has created unrealistic expectations, when the more immediate problem is that its own service information cannot answer the questions a patient now brings.

The best response is not to try to duplicate a conversational AI interface on every page. It is to identify the moments at which people need reassurance or clarity and build information around them. That includes:

• plain explanations of what a symptom, referral, test result or treatment pathway may involve;

• transparent boundaries on what the organisation can and cannot offer;

• practical preparation for appointments, including questions patients may wish to raise;

• clear escalation advice for urgent or worsening symptoms; and

• consistent details across the website, booking systems, call centres and printed communications.

None of this is glamorous. It is, however, the infrastructure of patient confidence. A health brand earns trust less through broad claims of expertise than through accurate, legible answers at the point uncertainty becomes consequential.

Research must follow the sequence, not just the source

There is a temptation to ask a blunt tracking question: “Did patients use AI?” It is increasingly too broad to guide a decision.

Insight teams should instead map the sequence around a defined health need. What prompted the initial search? Which question was handed to AI? What did the patient seek to validate afterwards? Which source changed their understanding? Did the information improve appointment readiness, reduce confusion or create another avoidable contact?

This requires research that combines behavioural evidence with patient accounts. Digital-path analysis can show movement between AI, search, provider sites and patient communities. Qualitative interviews can reveal why a person switched source and whether they understood the information they found. Service data can then establish whether the design is changing real outcomes, such as incomplete referrals, abandoned bookings, avoidable calls or missed preparation.

The important unit of analysis is not the page view or the prompt. It is the information hand-off between channels and, ultimately, between patient and professional.

That also calls for more disciplined segmentation. A person newly confronting a possible diagnosis has different informational needs from someone managing a long-term condition. Luth’s results suggest people with more experience of a chronic condition were more likely to combine AI with other sources and to spend longer researching. A single “digital patient” audience obscures such differences.

Build for the question after the answer

The strategic opportunity is straightforward: become the source patients use when an initial AI answer needs checking, applying or discussing with a clinician.

That means putting clinical and patient-experience teams at the centre of health-content design. Communications teams can make information easier to find and understand, but they cannot substitute for clear pathway ownership, current operational detail or a credible route to care.

It also means treating AI-generated health searches as a prompt to improve the underlying service. If patients repeatedly need an external tool to decode instructions, understand side effects or prepare for a consultation, that may indicate a weakness in letters, portals, consultation practice or follow-up communications.

The measure of success should therefore be more useful than traffic or share of search. Are patients better prepared? Do they reach the right service sooner? Do they understand the limits of self-service information? Are clinicians receiving more focused questions rather than having to repair avoidable confusion?

AI may shorten the distance between a worry and an explanation. It does not remove the need for trusted organisations to show their workings. In health, the decisive moment is often what happens after the first answer: whether a patient can verify it, place it in context and take an appropriate next step.